CLINICAL_TRIALS
trial_result
· 2019-11-27
Clinical Trial Update: Pharmacokinetic Single Dose Study of Oral Lasmiditan in Participants With Normal and Impaired Hepatic Function [Phase 1]
Summary
Phase 1 pharmacokinetic study of single-dose oral lasmiditan in participants with normal and impaired hepatic function completed; results posted.
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
Sponsor: Eli Lilly and Company | Conditions: Migraine | Phase 1 | Status: COMPLETED | Results posted: 2019-11-27